A new derivatizing agent, trimethylammoniopropyl methanethiosulphonate, is efficient for preparation of recombinant brain‐derived neurotrophic factor from inclusion bodies

Authors:
  • JAJiro Akimaru
    Jiro Akimaru
  • TNToyohiro Nishikawa
    Toyohiro Nishikawa
  • NSNoriaki Seki
    Noriaki Seki
  • HYHidenori Yamada
    Hidenori Yamada

Abstract
Derivatization with trimethylammoniopropyl methanethiosulphonate (TAPS‐sulphonate) enabled brain‐derived neurotrophic factor (BDNF) to be prepared efficiently fromEscherichia coliinclusion bodies. Reduced BDNF obtained from inclusion bodies solubilized by urea and reduced by dithiothreitol was suggested to form a complex with itself or with other compounds such as lipids. It could hardly be adsorbed on to cation‐exchange resin for partial purification prior to a refolding reaction. Reversible derivatization of cysteine residues was tested as a method of dissociating BDNF from such complexes. However, even if a methyl or aminoethyl group was introduced, BDNF could not be dissociated readily. Derivatization with TAPS‐sulphonate brought about good dissociation of BDNF, and more than 50% adsorbed on to the cation‐exchange resin. BDNF derivatized with TAPS‐sulphonate refolded well, and the refolded samples showed the same biological activity as purified BDNF. Derivatization with TAPS‐sulphonate would increase the intermolecular repulsion of BDNF, due to the positively charged character of the quaternized amine, and inhibit complex formation. Thus, TAPS‐sulphonate is effective for the preparation of BDNF under denatured conditions.

This publication has 29 references indexed in Scilit: